产品资料

人血管生成素-1|Human ANG-1

产品名称: 人血管生成素-1|Human ANG-1
产品型号: C02-130-06-20ug
产品展商: peprotech
产品文档: 无相关文档

简单介绍

人血管生成素-1|Human ANG-1系列产品主要适用于试验室或生化科研相关试验,CANSPEC品质提供人血管生成素-1|Human ANG-1性能**,中文名称为人血管生成素-1|Human ANG-1。产品人血管生成素-1|Human ANG-1以其优良的品质满足您不同科研实验的多种需求。


人血管生成素-1|Human ANG-1  的详细介绍

产品名称:人血管生成素-1|Human ANG-1

产品规格:

C02-130-06-20ug人血管生成素-1|Human ANG-120ug¥1,960
C02-130-06-5ug人血管生成素-1|Human ANG-15ug¥680

单        位:瓶

关 键 字:人血管生成素-1|Human ANG-1


CANSPEC品质提供的人血管生成素-1|Human ANG-1性能**,英文名称人血管生成素-1|Human ANG-1,简称为人血管生成素-1|Human ANG-1,中文名称为人血管生成素-1|Human ANG-1 。

产品人血管生成素-1|Human ANG-1以其优良的品质满足您不同实验的多种需求。并保证每批人血管生成素-1|Human ANG-1的质量和人血管生成素-1|Human ANG-1 品质优良。

Synonyms :

Angiopoietin-1

Description :

Angiopoietin-1 (Ang-1) is a secreted ligand for Tie-2, a tyrosine-kinase receptor expressed primarily on vascular endothelial cells and early hematopoietic cells. Ang-1/ Tie-2 signaling promotes angiogenesis during the development, remodeling, and repair of the vascular system. Transgenic mice lacking expression of either Ang-1 or Tie-2 fail to develop a fully functional cardiovascular system and die before birth. Postnatally, the angiogenic activity of Ang-1/Tie-2 is required during normal tissue repair and remodeling of the female endometrium in the menstrual cycle. Ang-1/Tie-2 signaling appears to be regulated by Angiopoietin-2 (Ang-2), a natural antagonist for Tie-2 that exerts its effects through an internal autocrine loop mechanism. In addition to suppressing endothelial cell activation by inhibiting the expression of adhesion and inflammatory molecules, Ang-1 enhances endothelial cell survival and capillary morphogenesis, and lessens capillary permeability. As such, Ang-1 has a potential to become an effective therapeutic agent for treating various endothelium disorders, including several severe human pulmonary diseases. The efficacy of cell-based Ang-1 gene therapy for acute lung injury (ALI) has recently been studied in a rat model of ALI (1). The results of this study show that such therapy can markedly improve lung condition and suggest that Ang-1 therapy may represent a potential new strategy for the treatment and/or prevention of acute respiratory distress injury (ARDI), a significant cause of morbidity and mortality in critically ill patients. Recombinant human ANG-1, derived from HeLa cells, is a C-terminal histidine tagged glycoprotein which migrates with an apparent molecular mass of 60.0 – 70.0 kDa by SDS-PAGE under reducing conditions. Sequencing analysis shows N-terminal sequences starting with Ser-20 and with Asp-70 of the 498 amino acid precursor protein.

Catalog #:

130-06

Source :

HeLa cells

Stability :

The lyophilized protein is stable for at least 2 years from date of receipt at -200C. Reconstituted ANG-1 is stable for at least 3 months when stored in working aliquots with a carrier protein at -200C. Avoid repeated freeze/thaw cycles.

Purity :

Greater than 95% by SDS-PAGE gel and HPLC analyses.

Endotoxin Level :

Endotoxin level is less than 0.1 ng per μg (1EU/μg).

Biological Activity :

Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC).

Selected References :

Selected List of References Citing This PeproTech Product

PubMed Link :

Angiopoietin-1

Country of Origin :

USA

 

 

沪公网安备 31011402005168号